Pre-Hospital Administration of Remdesivir During a Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Outbreak in a Skilled Nursing Facility.
Clinical Infectious Diseases · 2021-08-20 · Observational study
Abstract
Completion of a 5-day course of remdesivir was associated with approximately 17-fold increased odds of survival among a sample of 54 nursing home residents with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection during the course of an outbreak from October to December 2020. Remdesivir was well tolerated; administration was logistically feasible in a pre-hospital environment.
Abstract © the authors or publisher, via PubMed. Reuse and removal
Tags
Mortality & survival · Nursing & care homes · COVID-19 pandemic
Related articles
- COVID-19 among nursing home residents: results of an urgent pre-hospital intervention by a multidisciplinary task force. (Braz J Infect Dis, 2021)
- Clinical Characteristics of Patients With Coronavirus Disease 2019 (COVID-19) Receiving Emergency Medical Services in King County, Washington. (JAMA Netw Open, 2020)
- Prehospital Testing and Surveillance for SARS-CoV-2: A Special Report from the Sacramento (California USA) Mobile Integrated Health Unit. (Prehosp Disaster Med, 2022)
- Lessons learned from COVID-19 outbreak in a skilled nursing facility, Washington State. (J Am Coll Emerg Physicians Open, 2020)
- Pre-Hospital Management of Patients with COVID-19 and the Impact on Hospitalization. (Medicina (Kaunas), 2023)
- Excess Out-of-Hospital Mortality and Declining Oxygen Saturation: The Sentinel Role of Emergency Medical Services Data in the COVID-19 Crisis in Tijuana, Mexico. (Ann Emerg Med, 2020)